starting operations in 2012, iteos therapeutics is a clinical-stage biopharmaceutical company dedicated to extending and improving the lives of cancer patients by developing immunotherapies by design. iteos is developing eos200271, a clinical-stage potent 

iTeos Therapeutics, Inc. Common Stock

Bought to close all ITOS

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 